Pinchas Cohen

Last updated

Pinchas Cohen is the dean of the USC Leonard Davis School of Gerontology, holds the William and Sylvia Kugel Dean's Chair in Gerontology and serves as the executive director of the Ethel Percy Andrus Gerontology Center.

Cohen graduated in 1986 with highest honors from the medical school at Technion in Israel and trained at Stanford University between 1986 and 1992. He held his first faculty position at the University of Pennsylvania from 1992 to 1999. Until summer 2012, he was a professor and vice chair for research at the Mattel Children's Hospital UCLA at the Ronald Reagan UCLA Medical Center, as well as the co-director of the UCSD/UCLA Diabetes Research Center. [1] [2] He served on the advisory board for the Milken Institute Center for the Future of Aging. [3]

Research

He received numerous awards for his research, including a National Institute of Aging "EUREKA"-Award and the NIH-Director-Transformative R01-Grant. He also recently received the Glenn Award for Research in Biological Mechanisms of Aging. Cohen's research focuses on aging, neurodegeneration, cancer and diabetes with an emphasis on the emerging science of mitochondrial-derived peptides, which he discovered. [4] [5] He has also discussed the possibilities of applying personalized medicine to aging science, coining the term "personalized aging." [6] [7]

His laboratory was one of three teams that independently discovered humanin (Cohen and his team had been screening for proteins that interact with IGFBP3 [8] ). Other mitochondrial peptides discovered by the Cohen laboratory include SHLP 1, 2, 3, 4, 5, and 6 [9] [10] and MOTS-C. [11] [12]

He holds several patents for novel peptides and is the co-founder of CohBar, [13] a biotechnology company developing peptides found in mitochondria for diabetes treatment. [14] Cohen has published more than 250 papers in top scientific journals.

An expert in the field, Cohen was president of the Growth Hormone Society and served on the Endocrine Society Steering Committee. [15] [16] [17] He has sat on multiple NIH study sections and on several editorial boards. [18]

Related Research Articles

Beta cells (β-cells) are a type of cell found in pancreatic islets that synthesize and secrete insulin and amylin. Beta cells make up 50–70% of the cells in human islets. In patients with Type 1 diabetes, beta-cell mass and function are diminished, leading to insufficient insulin secretion and hyperglycemia.

<span class="mw-page-title-main">Glucose-dependent insulinotropic polypeptide</span> Mammalian protein found in Homo sapiens

Glucose-dependent insulinotropic polypeptide, abbreviated as GIP, is an inhibiting hormone of the secretin family of hormones. While it is a weak inhibitor of gastric acid secretion, its main role, being an incretin, is to stimulate insulin secretion.

The USC Leonard Davis School of Gerontology is one of the seventeen academic divisions of the University of Southern California in Los Angeles, focusing on undergraduate and graduate programs in gerontology.

James E. Birren was one of the founders of the organized field of gerontology. He was a past president of The Gerontological Society of America, and author of over 250 publications.

Eileen M. Crimmins is the AARP Chair in Gerontology at the USC Davis School of Gerontology of the University of Southern California. Her work focuses on the connections between socioeconomic factors and life expectancy and other health outcomes.

Caleb Ellicott Finch is an American academic who is a professor at the USC Davis School of Gerontology. Finch's research focuses on aging in humans, with a specialization in cell biology and Alzheimer's disease.

<span class="mw-page-title-main">Kelvin Davies</span>

Kelvin J. A. Davies is the James E. Birren Chair of Gerontology at the USC Davis School of Gerontology with a joint appointment in Dana and David Dornsife College of Letters, Arts and Sciences in biology. He is involved in researching free radical biology, oxidative stress, and aging; and was an early member of the study of protein oxidation, proteolysis, and altered gene expression during stress-adaptation; he also found the role of free radicals in mitochondrial adaptation to exercise, and demonstrated the role of diminished oxidative stress-adaptive gene expression in aging.

Christian Pike is a professor at the Leonard Davis School of Gerontology and a member of the USC Neuroscience Program. His ongoing work focuses on Alzheimer's disease and other age-related neurodegenerative disorders. His laboratory studies the role of neuronal apoptosis in neural diseases. Recently, his research found new use for synthetic estrogens in lessening the effects of Hormone Replacement Therapy for Alzheimer's patients.

Edward L. Schneider is a Professor of Gerontology at the USC Leonard Davis School of Gerontology, Professor of Medicine at the Keck School of Medicine of USC, with a joint appointment in biological sciences and molecular biology at the Dornsife College of Letters, Arts and Sciences.

<span class="mw-page-title-main">Forkhead box protein O1</span> Protein

Forkhead box protein O1 (FOXO1), also known as forkhead in rhabdomyosarcoma (FKHR), is a protein that in humans is encoded by the FOXO1 gene. FOXO1 is a transcription factor that plays important roles in regulation of gluconeogenesis and glycogenolysis by insulin signaling, and is also central to the decision for a preadipocyte to commit to adipogenesis. It is primarily regulated through phosphorylation on multiple residues; its transcriptional activity is dependent on its phosphorylation state.

Valter D. Longo is an Italian-American biogerontologist and cell biologist known for his studies on the role of fasting and nutrient response genes on cellular protection aging and diseases and for proposing that longevity is regulated by similar genes and mechanisms in many eukaryotes. He is currently a professor at the USC Davis School of Gerontology with a joint appointment in the department of Biological Sciences as well as serving as the director of the USC Longevity Institute.

<span class="mw-page-title-main">Fernando Torres-Gil</span> American policymaker

Fernando Torres-Gil graduated from San Jose State University in 1970 with a BA in Political Science, PhD, was the first Assistant Secretary for Aging at the Administration on Aging within the U.S. Department of Health and Human Services. He was appointed by President Clinton in 1993 and served in the position until 1997. Currently, Torres-Gil sits on the National Council on Disability as an appointee of President Obama. He is the Associate Dean of Academic Affairs and Professor of Social Welfare and Public Policy at the UCLA Luskin School of Public Affairs. He is the Director of the UCLA Center for Policy Research on Aging and is a member of the AARP Board of Directors. Torres-Gil also holds the position of Adjunct Professor of Gerontology at the USC Davis School of Gerontology, having served as Professor of Gerontology and Public Administration at USC before moving to UCLA. In December 2022, Torres-Gil as a fellow by the American Academy of Social Work and Social Welfare for 2023.

Sean Curran is an American gerontologist who is Professor of Gerontology and Vice Dean at the USC Davis School of Gerontology with joint appointments in Molecular and Computational Biology. He also serves as the Dean of Faculty and Research. His expertise is the molecular genetics of healthspan and longevity with an emphasis on biology, genetics, nutrition, and diets.

<span class="mw-page-title-main">Humanin</span> A micropeptide encoded by mitochondrial DNA and showing cytoprotective effects

Humanin is a micropeptide encoded in the mitochondrial genome by the 16S ribosomal RNA gene, MT-RNR2. Its structure contains a three-turn α-helix, and no symmetry.

Nir Barzilai is the founding director of the Institute for Aging Research, the Nathan Shock Center of Excellence in the Basic Biology of Aging and the Paul F. Glenn Center for the Biology of Human Aging Research at Albert Einstein College of Medicine (Einstein). He also directs the Longevity Genes Project, a genetics study of over 600 families of centenarians and their children. The participants are all Ashkenazi Jews, a group selected for their genetic homogeneity, which makes it easier to identify significant genetic variations. Barzilai found that many of the centenarians had very high levels of HDL. Barzilai also co-founded of CohBar, Inc., a biotechnology company developing mitochondria based therapeutics to treat diseases associated with aging.

<span class="mw-page-title-main">George Shannon (actor)</span>

George Shannon is an American professor of gerontology at the USC Leonard Davis School of Gerontology, inaugural holder of the Kevin Xu Chair in Gerontology, and director of the Rongxiang Xu Regenerative Life Science Laboratory. He is also a former television and film actor, particularly known for his appearances in soap operas, including How to Survive a Marriage, Search for Tomorrow, Generations, and General Hospital. He played a leading role in the 1973 French surreal drama film I Will Walk Like a Crazy Horse.

<span class="mw-page-title-main">Small humanin-like peptide</span>

Small humanin-like peptides (SHLPs) are a group of peptides encoded in the 16S ribosomal RNA region of mitochondrial genome. Six peptides of this group (SHLP1–6) have been identified so far, each peptide is of 20-38 amino-acid long. They are derived from the mitochondria and act as important retrograde signaling molecules in the cell. Their names were given because the SHLPs share some similar biological effects with the mitochondrial peptide Humanin.

<span class="mw-page-title-main">Mitochondrial theory of ageing</span> Theory of ageing

The mitochondrial theory of ageing has two varieties: free radical and non-free radical. The first is one of the variants of the free radical theory of ageing. It was formulated by J. Miquel and colleagues in 1980 and was developed in the works of Linnane and coworkers (1989). The second was proposed by A. N. Lobachev in 1978.

<span class="mw-page-title-main">Victor A. Regnier</span> American architect, professor, and researcher

Victor A. RegnierFAIA is an American architect, professor, and researcher. His research and publications have explored the creation and evaluation of residential settings for the physically and cognitively frail with special attention to northern European precedents.

David Morris Kipnis was an American endocrinologist and medical researcher at Washington University in St. Louis. He discovered the "incretin effect".

References

  1. "Pinchas Cohen Named Dean of USC Davis School of Gerontology". USC. Retrieved 23 July 2012.
  2. "Curriculum Vitae" (PDF). USC Leonard Davis School of Gerontology. Retrieved 3 January 2017.
  3. "Milken Institute Center for the Future of Aging Assembles Top Experts on Aging." December 1, 2015. http://www.milkeninstitute.org/newsroom/press-releases/view/288.
  4. "Cohen Lab".
  5. "Pinchas Cohen". USC Leonard Davis School of Gerontology. Retrieved 3 January 2017.
  6. "Personalized Aging". Next Avenue. 23 May 2016.
  7. "USC's Cohen on Personalized Aging, U.S. Health Care". Bloomberg.
  8. Ikonen, M; Liu, B; Hashimoto, Y; Ma, L; Lee, KW; Niikura, T; Nishimoto, I; Cohen, P (Oct 28, 2003). "Interaction between the Alzheimer's survival peptide humanin and insulin-like growth factor-binding protein 3 regulates cell survival and apoptosis". Proceedings of the National Academy of Sciences of the United States of America. 100 (22): 13042–7. Bibcode:2003PNAS..10013042I. doi: 10.1073/pnas.2135111100 . PMC   240741 . PMID   14561895.
  9. Cobb, L. J., Lee, C., Xiao, J., Yen, K., Wong, R. G., Nakamura, H. K., … Cohen, P. (2016). Naturally occurring mitochondrial-derived peptides are age-dependent regulators of apoptosis, insulin sensitivity, and inflammatory markers. Aging, 8(4), 796–808. http://doi.org/10.18632/aging.100943.
  10. "Small peptides show neuroprotective properties". Alzheimer's News Today. Retrieved 3 January 2017.
  11. Lee et al., 2015, Cell Metabolism 21, 443–454. March 3, 2015 ª2015 Elsevier Inc. https://dx.doi.org/10.1016/j.cmet.2015.02.009.
  12. "Newly discovered hormone helps mice lose weight". Popular Science. Retrieved 3 January 2017.
  13. "Pinchas Cohen, M.D. – Founder and Director – CohBar Inc". cohbar.com. Archived from the original on 2017-01-04.
  14. "Company Overview of CohBar, Inc". Bloomerg Businessweek. Retrieved 23 July 2012.
  15. Dunkel, Tom (2010-01-15). "Vigor Quest". The New York Times. Retrieved 23 July 2012.
  16. "USC Davis School of Gerontology Faculty Profile: Pinchas Cohen, M.D." USC. Retrieved 23 July 2012.
  17. "Recognizing and Overcoming Adherence Barriers in the Pediatric Setting: An Expert Interview With Pinchas Cohen, MD". Medscape. Retrieved 23 July 2012.
  18. "Curriculum Vitae" (PDF). USC Leonard Davis School of Gerontology. Retrieved 3 January 2017.